2023

1. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

   Science advances, Vol. 9, Núm. 33, pp. eadf6692

2. Druggable Targets in Cytokine Release Syndromes

   Clinical Cancer Research, Vol. 29, Núm. 21, pp. 4320-4322

3. Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy

   Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 23, pp. 4711-4727

4. Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists

   Molecular Therapy - Nucleic Acids, Vol. 33, pp. 668-682